Research Article

Utilization and Dose Optimization of Angiotensin-Converting Enzyme Inhibitors among Heart Failure Patients in Southwest Ethiopia

Table 2

Clinical and medication related characteristics of HF patients (n=308).

Characteristicsn (%)

Previous hospitalization

no132 (42.9)

Yes176 (57.1)

Duration

<2108 (35.1)

>=2200 (64.9)

NYHA class

I22 (7.1)

II137 (44.5)

III149 (48.4)

Frequently identified comorbidities

Ischemic heart disease139 (45.1)

Hypertension83 (26.9)

Valvular heart diseases66 (21.4)

Atrial fibrillation64 (20.8)

Diabetes mellitus52 (16.9)

Hyperthyroidism.22 (7.1)

Chronic kidney disease17 (5.5)

Number of comorbidities

<2115 (37.3)

≥2193 (62.7)

Number of medications157 (51)

 <5174 (56.5)

 ≥5144 (43.5)

Commonly used medications

 Loop diuretics240 (78.9)

 ACEIs230 (74.7)

 Beta-blockers189 (61.4)

 ACEIs + Beta-blockers180 (58.4)

 Antiplatelets187 (60.7)

 Statins134 (43.5)

 Potassium sparing diuretics68 (22.1)

 Cardiac glycosides58 (18.8)

ACEIs, angiotensin converting enzyme inhibitors; NYHA, New York Heart Association.